Health
Pfizer-BioNTech vaccine appears effective against mutation in new coronavirus variants: Study – The Straits Times
A study indicated the vaccine was effective in neutralising virus with the so-called N501Y mutation of the spike protein.. Read more at straitstimes.com.
NEW YORK (REUTERS) – Pfizer and BioNTech’s Covid-19 vaccine appeared to work against a key mutation in the highly transmissible new variants of the coronavirus discovered in Britain and South Africa, according to a laboratory study conducted by the US drugmaker.
The not-yet peer reviewed study by Pfizer and scientists from the University of Texas Medical Branch indicated the vaccine was effective in neutralising virus with the so-called N501Y mutation of the spike protein.
The mutation could be…
-
Business22 hours agoForget CBA and buy these high-yield ASX dividend shares
-
General23 hours agoWhy an Australian journalist is teaching meditation in America’s toughest jails
-
Noosa News23 hours ago“There’s No Going Back”: The Grid Meets the Real World in the Initial Trailer for Third ‘TRON’ Movie ‘Ares’
-
Business23 hours agoTop brokers name 3 ASX shares to buy next week 6 April 2025